[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338222-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338222-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cancer-therapeutic-potential-and-prognostic-value-of-the-slc25-mitochondrial-carrier-family-a-review","Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family - A Review","","Solute carrier family 25 (SLC25) transporters regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins across mitochondrial and cytoplasmic compartments. This review explains how these transport processes connect to mitochondrial function, cellular metabolism regulation, and the capacity to supply energy. It highlights diverse and complex pathways by which SLC25 members influence tumorigenesis and progression. The work further emphasizes their potential as cancer therapeutic targets and prognostic biomarkers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cancer-therapeutic-potential-and-prognostic-value-of-the-slc25-mitochondrial-carrier-family-a-review/338222/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cancer-therapeutic-potential-and-prognostic-value-of-the-slc25-mitochondrial-carrier-family-a-review/338222.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does the SLC25 family influence mitochondrial and cellular metabolism?","Question",{"text":63,"@type":64},"SLC25 transporters control the distribution and concentration of key metabolites between mitochondrial and cytoplasmic compartments. These changes affect mitochondrial function, energy supply, and downstream metabolic states.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role do SLC25 members play in cancer biology?",{"text":68,"@type":64},"The review describes pathways through which SLC25 transport processes contribute to tumorigenesis and cancer progression. It links transporter-mediated substrate handling to phenotypic changes in cancer cells.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are SLC25 transporters considered promising cancer therapeutic targets and biomarkers?",{"text":72,"@type":64},"Because specific SLC25 members can impact essential metabolic processes in cancer cells, they offer targetable mechanisms. Their relevance to tumor behavior also supports their use as prognostic biomarkers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338222,1790194244,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review  \nCancer Control Volume 31: 1–17  \n© The Author(s) 2024  \nArticle reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)  \n[DOI: 10.1177/10732748241287905](DOI: 10.1177/10732748241287905)[ ](DOI: 10.1177/10732748241287905)[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)  \nRenzhuo Gao, BS 1 􀀁, Dan Zhou, BS2 􀀁, Xingpeng Qiu, BS2 􀀁, Jiayi Zhang, BS1 􀀁 ,  \nDaya Luo, PhD2 􀀁, Xiaohong Yang, MM2 􀀁, Caiyun Qian, MM3, and Zhuoqi Liu, PhD2 􀀁  \nAbstract  \nTransporters of the solute carrier family 25 (SLC25) regulate the intracellular distribution and concentration of nucleotides, amino acids, dicarboxylates, and vitamins within the mitochondrial and cytoplasmic matrices. This mechanism involves changes in mitochondrial function, regulation of cellular metabolism, and the ability to provide energy. In this review, important members of the SLC25 family and their pathways affecting tumorigenesis and progression are elucidated, highlighting the diversity and complexity of these pathways. Furthermore, the signiﬁcant potential of the members of SLC25 as both cancer therapeutic targets and biomarkers will be emphasized.  \nKeywords  \nsolute carrier family 25, mitochondrial carrier family, mitochondrial function, therapeutic targets, biomarkers  \nReceived May 23, 2024. Received revised August 29, 2024. Accepted for publication September 10, 2024.  \nIntroduction  \nCancer is among the most daunting health challenges, and it always affects humanity as it causes millions of deaths annually.1 The tremendous progress made towards the knowledge of the molecular basis of cancer and the development of targeted therapies is still not sufﬁcient, as the disease is complex. Thus, the search for new therapeutic targets and prognostic markers is a process that never ends.2,3 In this instance, mitochondria, frequently considered as the cellular powerhouses, have become key players in cancer biology. They profoundly affect the substance metabolism and energy supply of cells through multiple metabolic pathways such as tricarboxylic acid cycle, fatty acid oxidation, oxidative phosphorylation and so on, affecting cell death, proliferation and metastasis.4 The solute carrier family 25 (SLC25) is an element related to mitochondrial function, and its role in ion transport has attracted the attention of researchers.  \nThe Mitochondrial Carrier Family was initially discovered in S. cerevisiae and is currently the largest human solute  \ntransport protein family, with 53 members (Figure 1) .5 The SLC25 family is mostly present in the inner mitochondrial membrane and transports fatty acids, amino acids, carboxylic acids, inorganic ions, and other metabolic products. It is highly conserved and features a three-domain structure with six transmembrane α-helices, along with a 3-fold repeated motif of hydrophobic and charged residues. This symmetry serves as  \n1 School of Queen Mary, Jiangxi Medical College, Nanchang University, Nanchang, China  \n2School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China  \n3Department of Blood Transfusion, Key Laboratory of Jiangxi Province for Transfusion Medicine, The First Afﬁliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China  \nCorresponding Author:  \nZhuoqi Liu, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, No. 461 Bayi Avenue, Dongjiayao Street, Donghu District, Nanchang, Jiangxi Province 330031, China.  \nEmail: [liuzhuoqi@ncu.edu.cn](liuzhuoqi@ncu.edu.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution of the work without furthe","cbCaicMNiMdHServ","https://ap.wps.com/l/cbCaicMNiMdHServ","pdf",1498638,17,"English","# Introduction\n# SLC25 family structure and mitochondrial localization\n## Transport mechanisms and metabolic regulation\n# SLC25 members in tumorigenesis and progression\n## Therapeutic target potential\n## Prognostic biomarker potential","[{\"question\":\"How does the SLC25 family influence mitochondrial and cellular metabolism?\",\"answer\":\"SLC25 transporters control the distribution and concentration of key metabolites between mitochondrial and cytoplasmic compartments. These changes affect mitochondrial function, energy supply, and downstream metabolic states.\"},{\"question\":\"What role do SLC25 members play in cancer biology?\",\"answer\":\"The review describes pathways through which SLC25 transport processes contribute to tumorigenesis and cancer progression. It links transporter-mediated substrate handling to phenotypic changes in cancer cells.\"},{\"question\":\"Why are SLC25 transporters considered promising cancer therapeutic targets and biomarkers?\",\"answer\":\"Because specific SLC25 members can impact essential metabolic processes in cancer cells, they offer targetable mechanisms. Their relevance to tumor behavior also supports their use as prognostic biomarkers.\"}]","Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family - A Review | PDF",1790022608,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/497ea7857774d33a6528419e3b62ad89.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9277c1a56a6ae1f080dd15c27e4e854d.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04195566b68f2603ce1eeabbec7930fd.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d6ef6239c709175fcef6a37b3969f4b.webp",980,1268]